Trial NCT02433483

View at ClinicalTrials.gov 
Org. Study IDs: MITREL
Secondary IDs: NCI-2015-00691

Last trial update was posted on 2017-11-01

MeSH Interventions

Cytarabine Hydrocortisone Methotrexate

MeSH Conditions

Hematologic Neoplasms Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia

Other Conditions

Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)

Stopping Reasons

The study was closed due to poor accrual and because of competing protocols.

Limitations And Caveats

This study was terminated in May 2017 due to poor accrual and because of competing protocols.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID